June 11 (Reuters) - Correvio Pharma Corp CORV.TO :
* CORREVIO PROVIDES U.S. REGULATORY UPDATE FOR BRINAVESS
* CORREVIO PHARMA CORP - TO SCHEDULE A PRE-NDA MEETING TO DISCUSS CONTENT AND FORMAT OF A POTENTIAL RESUBMISSION OF NDA
* CORREVIO - EXPECTS PRE-NDA MEETING FOR BRINAVESS, CO'S ANTIARRHYTHMIC DRUG FOR RAPID CONVERSION OF RECENT ONSET ATRIAL FIBRILLATION, TO BE IN Q4 2018